J. Collins

发表

Risk factors for invasive breast cancer when core needle biopsy shows ductal carcinoma in situ.

E. Kurniawan, A. Rose, Arlene Mou, 2010, Archives of surgery.

Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IV.

R. Gelber, A. Goldhirsch, J. Collins, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Immunolymphoscintigraphy for the detection of lymph node metastases from breast cancer.

J. Tjandra, J. Collins, J. Andrews, 1989, Cancer research.

Present and future projects of the international breast cancer study group

J. Forbes, F. Cavalli, R. Gelber, 1994, Cancer.

Spindle cell lipoma of the breast.

J. Collins, N. Mulvany, A. Silvester, 1999, Pathology.

The management of early breast carcinoma before and after the introduction of clinical practice guidelines

G. Giles, J. Collins, J. Boyages, 2004, Cancer.

CHANGES IN THE MANAGEMENT OF DUCTAL CARCINOMA IN SITU BEFORE THE RELEASE OF CLINICAL PRACTICE RECOMMENDATIONS IN AUSTRALIA: THE CASE IN VICTORIA

G. Giles, J. Collins, V. White, 2006, ANZ journal of surgery.

Surgical management of ductal carcinoma in situ in Australia in 1995

J. Collins, V. White, D. Hill, 2002, ANZ journal of surgery.

Comparison of blue dye and isotope with blue dye alone in breast sentinel node biopsy

J. Collins, G. Mann, D. Syme, 2005, ANZ journal of surgery.

Implementation of image-guided large-core needle biopsy of the breast on a limited budget.

J. Collins, A. Doyle, A. King, 1998, Australasian radiology.

Prostate cancer trends in Canada: rising incidence or increased detection?

J. Collins, D. G. Perkins, Y. Mao, 1993, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Outcomes of Screening-Detected Ductal Carcinoma In Situ Treated with Wide Excision Alone

E. Kurniawan, A. Rose, Arlene Mou, 2011, Annals of surgical oncology.

Changes in the investigation and management of primary operable breast cancer in Victoria

G. Giles, J. Collins, V. White, 1994, The Medical journal of Australia.

Comparison of mammary serum antigen assay with mammography in patients with breast cancer

J. Tjandra, J. Collins, I. Russell, 1988, The Medical journal of Australia.

The detection of axillary lymph node metastases from breast cancer by radiolabelled monoclonal antibodies: a prospective study.

J. Tjandra, J. Collins, J. Andrews, 1989, British Journal of Cancer.

“Best practice” in surgical management of breast cancer

J. Collins, 1997, The Medical journal of Australia.

Decreased immunoreactivity for p27 protein in patients with early‐stage breast carcinoma is correlated with HER‐2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status

R. Gelber, B. Gusterson, A. Goldhirsch, 2003, Cancer.

A randomised study to compare the effect of the luteinising hormone releasing hormone (LHRH) analogue goserelin with or without tamoxifen in pre- and perimenopausal patients with advanced breast cancer.

A. Howell, J. Forbes, R. Blamey, 1995, European journal of cancer.

Results of first line endocrine therapy for advanced breast cancer in premenopausal women with skeletal metastases only

A. Howell, J. Forbes, R. Blamey, 1993 .

Secondary Colonic Adenocarcinoma of the Prostate Histologically Mimicking Prostatic Ductal Adenocarcinoma

J. Collins, K. Mai, D. Landry, 2002, Tumori.

Sequential alternating medroxyprogesterone acetate and epirubicin in the treatment of advanced breast cancer.

J. Collins, I. Russell, M. Green, 1989, The Australian and New Zealand journal of surgery.

Multicycle high-dose chemotherapy and filgrastim-mobilized peripheral-blood progenitor cells in women with high-risk stage II or III breast cancer: five-year follow-up.

C. Begley, J. Collins, J. Szer, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect on immunologic and other indices of adjuvant cytotoxic chemotherapy including melphalan in breast cancer

I. Mackay, J. Collins, I. Russell, 1984, Cancer.

Participation in the RACS Sentinel Node Biopsy versus Axillary Clearance Trial

M. Stockler, V. Gebski, J. Collins, 2005, ANZ journal of surgery.

Multicycle H igh-Dose C hemotherapy a nd Filgrastim-Mobilized P eripheral-Blood P rogenitor C ells in W omen W ith H igh-Risk S tage I I o r I II B reast C ancer: Five-Year F ollow-Up

C. Begley, J. Collins, J. Szer, 1999 .

Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group report.

J. Forbes, R. Gelber, A. Goldhirsch, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Rapid hematopoietic recovery after multicycle high-dose chemotherapy: enhancement of filgrastim-induced progenitor-cell mobilization by recombinant human stem-cell factor.

C. Begley, J. Collins, J. Szer, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Predictors of Surgical Margin Status in Breast-Conserving Surgery Within a Breast Screening Program

Malcolm Buchanan, E. Kurniawan, A. Rose, 2008, Annals of surgical oncology.

Unusual side effect of mitoxantrone

J. Collins, I. Russell, J. Sullivan, 1983, Medical Journal of Australia.

Prostatic Adenocarcinoma with Urothelial (Transitional Cell) Carcinoma Features

J. Collins, K. Mai, J. Veinot, 2002, Applied immunohistochemistry & molecular morphology : AIMM.

Absence of serum prostate-specific antigen and loss of tissue immunoreactive prostatic markers in advanced prostatic adenocarcinoma after hormonal therapy: a report of two cases.

J. Collins, K. Mai, D. G. Perkins, 1996, Human pathology.

Mitoxantrone treatment in advanced breast cancer.

J. Collins, I. Russell, J. Andrews, 1984, The Australian and New Zealand journal of surgery.

Prognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical cyclophosphamide, methotrexate, and fluorouracil: long-term observations from International Breast Cancer Study Group Trial VI.

M. Bonetti, R. Gelber, A. Goldhirsch, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ki‐67 expression in breast carcinoma

R. Gelber, B. Gusterson, A. Goldhirsch, 2003, Cancer.

Composite renal cell carcinoma and angiomyolipoma: A study of the histogenetic relationship of the two lesions

J. Collins, K. Mai, S. Robertson, 1999, Pathology international.

Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG).

R. Gelber, A. Goldhirsch, J. Collins, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12–93

J. Forbes, R. Gelber, A. Goldhirsch, 2009, Breast Cancer Research and Treatment.

CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials.

A. Goldhirsch, J. Collins, B. Thürlimann, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII.

J. Forbes, R. Gelber, A. Goldhirsch, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A comparative study of metastatic renal cell carcinoma with correlation to subtype and primary tumor.

J. Collins, K. Mai, B. Burns, 2001, Pathology, research and practice.

Renal angiomyolipoma: a tumour with peculiar variants and associations

J. Collins, K. Mai, D. G. Perkins, 1996, Histopathology.

Comparison of mammary serum antigen (MSA) and CA15-3 levels in the serum of patients with breast cancer.

J. Collins, I. Russell, I. McKenzie, 1987, British Journal of Cancer.

Comparison of mammary serum antigen (MSA) with β2-microglobulin (β2M) and carcinoembryonic antigen (CEA) assays in patients with breast cancer

P. McLaughlin, J. Tjandra, J. Collins, 1988 .

Comparison of mammary serum antigen (MSA) with beta 2-microglobulin (beta 2M) and carcinoembryonic antigen (CEA) assays in patients with breast cancer.

P. McLaughlin, J. Tjandra, J. Collins, 1988, European journal of cancer & clinical oncology.

Adjuvant treatment of high-risk breast cancer using multicycle high-dose chemotherapy and filgrastim-mobilized peripheral blood progenitor cells.

C. Begley, J. Collins, J. Szer, 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

Transitional Zone and Anterior Peripheral Zone of the Prostate

J. Collins, C. Morash, K. Mai, 2001, Urologia Internationalis.

Site of primary tumor has a prognostic role in operable breast cancer: the international breast cancer study group experience.

R. Gelber, A. Goldhirsch, J. Collins, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Colonic and breast carcinomas--association or metastases? Report of a case.

J. Tjandra, J. Collins, I. Russell, 1990, Singapore medical journal.

Management of primary, operable breast cancer in Victoria

G. Giles, J. Collins, D. Hill, 1990, The Medical journal of Australia.

The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer.

J. Forbes, R. Gelber, B. Gusterson, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Risk F actors f or L ocoregional R ecurrence A mong B reast Cancer P atients: R esults F rom I nternational B reast C ancer Study G roup T rials I T hrough V II

M. Bonetti, A. Goldhirsch, J. Collins, 2003 .

Surgical management of breast cancer in Australia in 1995

G. Giles, J. Collins, J. Boyages, 1999 .

The use of tissue expansion for immediate breast reconstruction after mastectomy

J. Collins, I. Russell, A. Holmes, 1990, The Medical journal of Australia.

Incidental prostatic adenocarcinomas and putative premalignant lesions in TURP specimens collected before and after the introduction of prostrate-specific antigen screening.

J. Collins, C. Morash, K. Mai, 2009, Archives of pathology & laboratory medicine.

Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93

J. Forbes, R. Gelber, A. Goldhirsch, 2008, Breast Cancer Research and Treatment.

Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century

R. Gelber, A. Goldhirsch, J. Collins, 2009, Breast Cancer Research and Treatment.

Carbon localisation of impalpable breast lesions.

A. Rose, J. Collins, G. Mann, 2003, Breast.

Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer.

R. Gelber, B. Gusterson, A. Goldhirsch, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Comparison ofmammary serumantigen (MSA)andCA15-3levels inthe serumofpatients withbreast cancer

J. Collins, I. Russell, I. Mckenzie, 1987 .

Uptake of adjuvant breast cancer treatments recommended by multi‐disciplinary meetings

C. Nickson, A. Rose, Arlene Mou, 2018, ANZ journal of surgery.

Application of mammary serum antigen assay in the management of breast cancer: A preliminary report

J. Collins, S. Stacker, I. Russell, 1988, The British journal of surgery.

Vascular myxolipoma ("angiomyxolipoma") of the spermatic cord.

J. Collins, K. Mai, H. Yazdi, 1996, The American journal of surgical pathology.

Mastectomy with tears: breast cancer surgery in the early nineteenth century

J. Collins, 2016, ANZ journal of surgery.

Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience.

A. Goldhirsch, J. Collins, A. Coates, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer.

R. Gelber, B. Gusterson, A. Goldhirsch, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Treatment Intensity Differences After Early-Stage Breast Cancer (ESBC) Diagnosis Depending on Participation in a Screening Program

C. Nickson, A. Rose, Arlene Mou, 2018, Annals of surgical oncology.

Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII.

J. Forbes, M. Bonetti, R. Gelber, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience.

A. Goldhirsch, J. Collins, A. Coates, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Toward further reducing wound infections in cardiac operations.

J. Collins, I. Brown, W. Marshall, 1996, The Annals of thoracic surgery.

Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG).

R. Gelber, A. Goldhirsch, J. Collins, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII.

J. Forbes, M. Bonetti, R. Gelber, 2003, Journal of Clinical Oncology.

Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumor.

A. Goldhirsch, J. Collins, A. Coates, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.